Detalhe da pesquisa
1.
Trends of humoral immune responses to heterologous antigenic exposure due to vaccination & omicron SARS-CoV-2 infection: Implications for boosting.
Indian J Med Res
; 157(6): 509-518, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37322634
2.
A quest for universal anti-SARS-CoV-2 T cell assay: systematic review, meta-analysis, and experimental validation.
NPJ Vaccines
; 9(1): 3, 2024 Jan 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38167915
3.
Clinical and experimental evidence suggest omicron variant of SARS-CoV-2 is inherently less pathogenic than delta variant independent of previous immunity.
Eur J Med Res
; 28(1): 421, 2023 Oct 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37821945
4.
Sub-optimal neutralisation of omicron (B.1.1.529) variant by antibodies induced by vaccine alone or SARS-CoV-2 Infection plus vaccine (hybrid immunity) post 6-months.
EBioMedicine
; 78: 103938, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35305396